Status:
COMPLETED
Analgesic Treatment Mediated by Arcoxia (0663-093)
Lead Sponsor:
Organon and Co
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Allow physicians to test the efficacy of arcoxia in patients with acute pain.
Eligibility Criteria
Inclusion
- Diagnosis of acute pain susceptible of pharmacological treatment
- Greater than 18 years of age
- Voluntary acceptance to participate in the study and signature of the informed consent form
Exclusion
- Allergy to etoricoxib or any of its components
- Less than 18 years old
- Patient is taking anticoagulants
- Patient that already has taken any drug as analgesic
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2005
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT00380523
Start Date
April 1 2005
End Date
May 1 2005
Last Update
February 16 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.